Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CECELIA C DAMASK

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1790756955
CMS profile
125994
Location
ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$77,943.72

124 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

124 matching records · $77,943.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 124 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 124.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $3,000.0012/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801927863 CMS
Optinose US, Inc. $6.1612/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026851646599 CMS
Regeneron Pharmaceuticals, Inc. $970.0012/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809680875 CMS
Regeneron Pharmaceuticals, Inc. $1,940.0012/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809680877 CMS
Novartis Pharmaceuticals Corporation $22.4712/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812650253 CMS
GlaxoSmithKline, LLC. $3,600.0012/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801934549 CMS
AstraZeneca Pharmaceuticals LP $11.8812/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829512733 CMS
Optinose US, Inc. $22.0512/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026851646601 CMS
GENZYME CORPORATION $5,607.0012/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732013 CMS
GENZYME CORPORATION $273.3512/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732015 CMS
GENZYME CORPORATION $713.6012/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732017 CMS
GENZYME CORPORATION $104.9912/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732019 CMS
GENZYME CORPORATION $194.2412/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732021 CMS
GENZYME CORPORATION $2,403.0012/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732023 CMS
GENZYME CORPORATION $224.8512/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732025 CMS
GENZYME CORPORATION $32.9512/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732027 CMS
GENZYME CORPORATION $713.6012/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732029 CMS
GENZYME CORPORATION $110.0312/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732031 CMS
SANOFI-AVENTIS U.S. LLC $24.9512/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843731999 CMS
ALK-Abello, Inc $750.0011/29/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809197041 CMS
AstraZeneca Pharmaceuticals LP $15.3511/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829347721 CMS
GlaxoSmithKline, LLC. $1,065.4811/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801849143 CMS
GlaxoSmithKline, LLC. $123.1711/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801959349 CMS
GENZYME CORPORATION $120.9111/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732007 CMS
GENZYME CORPORATION $4,806.0011/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732009 CMS
GENZYME CORPORATION $995.0311/18/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843732011 CMS
GlaxoSmithKline, LLC. $8,450.0011/16/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802859807 CMS
Novartis Pharmaceuticals Corporation $20.2111/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812650251 CMS
AstraZeneca Pharmaceuticals LP $111.9211/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829407273 CMS
GlaxoSmithKline, LLC. $5.8111/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801843551 CMS
Novartis Pharmaceuticals Corporation $23.6011/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812650237 CMS
Genentech USA, Inc. $32.7111/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835895465 CMS
GlaxoSmithKline, LLC. $47.6711/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802979793 CMS
SANOFI-AVENTIS U.S. LLC $25.3811/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843731983 CMS
AstraZeneca Pharmaceuticals LP $15.4511/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829534421 CMS
AstraZeneca Pharmaceuticals LP $466.4411/03/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830079571 CMS
Novartis Pharmaceuticals Corporation $71.0810/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812650235 CMS
GENZYME CORPORATION $13.9510/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843731979 CMS
AstraZeneca Pharmaceuticals LP $14.9810/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829817677 CMS
GENZYME CORPORATION $34.8310/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843731991 CMS
Optinose US, Inc. $23.1410/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026851646593 CMS
GlaxoSmithKline, LLC. $108.1910/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802998119 CMS
kaleo, Inc. $22.6210/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832116611 CMS
AstraZeneca Pharmaceuticals LP $15.5110/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830166689 CMS
GlaxoSmithKline, LLC. $3,600.0010/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802920763 CMS
ALK-Abello, Inc $750.0010/03/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809197037 CMS
GlaxoSmithKline, LLC. $66.0710/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026803209929 CMS
GlaxoSmithKline, LLC. $1,200.0009/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801843927 CMS
GlaxoSmithKline, LLC. $600.0009/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802918705 CMS
GlaxoSmithKline, LLC. $4,550.0009/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026803038019 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $45,428.03 165
PY2020 $35,168.51 80
PY2021 $77,943.72 124
PY2022 $70,938.68 133
PY2023 $88,455.87 125
PY2024 $205,422.19 228
PY2025 $183,233.32 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
CECELIA C DAMASK, NPI 1790756955. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1790756955.
APA 7
IndustryPayments. (2026). CECELIA C DAMASK, NPI 1790756955 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1790756955
Bluebook
CECELIA C DAMASK, NPI 1790756955, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1790756955.

Source: Centers for Medicare & Medicaid Services, Open Payments.